ID
20963
Description
Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C; ODM derived from: https://clinicaltrials.gov/show/NCT00265642
Link
https://clinicaltrials.gov/show/NCT00265642
Keywords
Versions (1)
- 3/31/17 3/31/17 -
Uploaded on
March 31, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hepatitis C, Chronic NCT00265642
Eligibility Hepatitis C, Chronic NCT00265642
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Liver carcinoma
Data type
boolean
Alias
- UMLS CUI [1]
- C2239176
Description
HIV Infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0019693
Description
Alcohol abuse
Data type
boolean
Alias
- UMLS CUI [1]
- C0085762
Description
Liver Cirrhosis
Data type
boolean
Alias
- UMLS CUI [1]
- C0023890
Description
antifibrotic agents
Data type
boolean
Alias
- UMLS CUI [1]
- C4031950
Description
Pregnancy | Breast Feeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Similar models
Eligibility Hepatitis C, Chronic NCT00265642
- StudyEvent: Eligibility
C1954437 (UMLS CUI [2])
C0332197 (UMLS CUI [1,2])
C0280274 (UMLS CUI [1,2])
C0438286 (UMLS CUI [1,2])
C0280274 (UMLS CUI [2,1])
C0277556 (UMLS CUI [2,2])
C0006147 (UMLS CUI [2])